Taichung Veterans General Hospital
Recent findings in atherosclerosis described by researchers from Taiwan, the United States and Italy
Published in Healthcare Finance, Tax and Law Weekly, June 14th, 2006
Study 1: Angiogenesis is impaired by rosiglitazone's effects on endothelial cells.
"Rosiglitazone, an insulin sensitizer, is known to offer beneficial effects in retarding atherosclerotic vascular diseases. Since proliferation and angiogenesis are involved in initiation and plaque instability, two critical steps in the cardiovascular events, this study was designed to evaluate the mechanisms of rosiglitazone on endothelial proliferation and angiogenesis," researchers in Taiwan report.
"Rosiglitazone-treated human umbilical vein...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AFP Imaging Corp.
AFP Imaging reports 15% increase in sales - ALS Association
Group joins funding partnership for new hunt for amyotrophic lateral sclerosis genes - Acadia Pharmaceuticals, Inc.
Acadia Pharmaceuticals added to NASDAQ Biotech Index - Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals reports 7% decrease in sales - Adams Respiratory Therapeutics, Inc.
Adams Respiratory Therapeutics added to NASDAQ Biotech Index - Adherex Technologies, Inc.
Adherex posts net loss of $0.08 per share - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
